MANDELIA ASHISH (VP, Controller) sold 2.0% of their position (1.01K shares) of MERSANA THERAPEUTICS, INC. on the open market
Open‑market sale worth $664.62 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/15/2025ACC: 0001104659-25-003879
Officer· VP, Controller
Since Jan 2020
-1.01K
Net shares
Net seller
$664.62
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.65K acquired · 3.65K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.65K
Price / share
—
Trade value
—
% of position
5.5%
1/13/2025
47.76K→50.40K
Common Stock
Direct
Shares
−1.01K
Price / share
$0.66
Trade value
$664.62
% of position
2.0%
1/14/2025
50.40K→49.40K
Total
Net shares
+1.64K
Net value
-$664.62
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2025 | M · Option Exercise | +2.65K | — | — | 5.5% | 47.76K | 50.40K |
| Common Stock Direct | 1/14/2025 | S · Sale | −1.01K | $0.66 | $664.62 | 2.0% | 50.40K | 49.40K |
| Total | +1.64K | -$664.62 | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
2.65K shares
Shares
−2.65K
Strike price
Held after
5.29K
Exercisable
—
1/13/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock2.65K shares | 1/13/2025 | M · Option Exercise | −2.65K | — | 5.29K |